Practice trends in the management of prostate disease by family practice physicians and general internists: An internet-based survey

Urology

Volumn 59, Issue 2, 2002, Pages 266-271

  Kim, Hyung L ^a   Benson, David A ^a   Stern, Scott D ^a   Gerber, Glenn S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RISK; CANCER SCREENING; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INTERNAL MEDICINE; INTERNET; MEDICAL PRACTICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

AGED; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERNAL MEDICINE; INTERNET; MALE; PALPATION; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0036166721     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01504-7     Document Type: Article

References (21)

1. Cancer statistics, 1999
2. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia
3. Epidemiology and natural history of benign prostatic hyperplasia
4. American Cancer Society guidelines for the early detection of prostate cancer; update, June 10, 1997
5. The U.S. Preventive Services Task Force Guide to Clinical Preventive Services
6. Clinical guideline-part III; screening for prostate cancer
7. Benign Prostatic Hyperplasia: Diagnosis and Treatment
8. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer
9. Primary care practitioners; an analysis of their perceptions of voiding dysfunction and prostate cancer
10. Appendix F-periodic health examination
11. Variation in recommendations for cancer screening among primary care physicians in New Mexico
12. General practi-tioners' perceptions of medicolegal risk; using case scenarios to assess the potential impact of prostate cancer screening guidelines
13. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer
14. Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia; rationale and clinical experience
15. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia
16. Improvement of pressure flow parameters with finasteride is greater in men with large prostates
17. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years; characterization of patients and ultimate outcomes
18. Prevalence and patterns of the use of complementary therapies among prostate cancer patients; an epidemiological analysis
19. Saw palmetto extracts for treatment of benign prostatic hyperplasia; a systematic review
20. Use of new technology in endourology and laparoscopy by American urologists; Internet and postal survey
21. Practice patterns in the treatment of female urinary incontinence; a postal and Internet survey